Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/e4a946c6-8ff7-458d-8752-7d128cb07aac/
MEDANTA
Global Health LimitedSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
5.0%ile
P/E
59.9×
P/S
7.6×
P/B
8.4×
E/P
0.0167
FCF Yield
-0.008
EBITDA/EV
0.030
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
95.00000000
/100 — 1=cheapest
VC2 (Trending Value)
96.00000000
/100
VC3 (Buyback)
96.00000000
/100
P/E of 59.9x is premium-priced — the market is paying up for expected growth. Negative FCF yield (-0.8%) — the business is currently cash-consumptive. VC2 score of 96.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
74.0%ile
ROE
0.140
ROA
0.094
Net Margin
0.126
Op Margin
0.158
GPA
0.578
Current
2.67
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.194
Earn Growth
0.155
Stability
0.237
lower=better
Accruals
-0.027
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
72.0%ile
6M Return
6.6%
12M Return
2.0%
12-1 Mom
-1.2%
Risk-Adj
-0.04
Vol 252d
29.5%
Vol 60d
63.7%
↑ Expanding
Max DD 12M
-30.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (64%) is expanding vs long-term (29%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.24
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 160 peers
Sector Value %ile
11.2%
Sector Quality %ile
56.5%
P/E z-score
-0.09
P/B z-score
0.60
Sector Avg OS
43.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
| Symbol | Name | OS | Value | Quality | Momentum |
|---|---|---|---|---|---|
| NATCOPHARM | 98.0% | 88.0% | 87.0% | 81.0% | |
| UNIVPHOTO | 97.0% | 86.0% | 74.0% | 94.0% | |
| LINCOLN | 97.0% | 88.0% | 80.0% | 81.0% | |
| STAR | 96.0% | 73.0% | 91.0% | 91.0% | |
| VENUSREM | 96.0% | 68.0% | 94.0% | 99.0% | |
| HALEOSLABS | 95.0% | 82.0% | 77.0% | 81.0% | |
| AUROPHARMA | 94.0% | 71.0% | 84.0% | 87.0% | |
| SPARC | 93.0% | 72.0% | 86.0% | 83.0% |
Factor Interactions
Quality Momentum — Expensive
Strong quality (74th) and momentum (72th) but expensive (5th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (74th) but expensive (5th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (64%) significantly exceeds 252-day (29%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
13.8% avg (7 factors)
Quality
B
66.1% avg (7 factors)
Momentum
D
34.2% avg (4 factors)
Risk
B
67.5% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.240 | —1 | — | |
| Value %ile | 0.050 | —1 | — | |
| Quality %ile | 0.740 | —1 | — | |
| Momentum %ile | 0.720 | —1 | — | |
| F-Score | 5.000 | —0 | — | |
| Confidence | 0.939 | —1 | — | |
| Volatility | 0.295 | —0 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
59.88
Earnings Yield (E/P)
0.0167
Price / Sales
7.55
Price / Book
8.41
Price / Cash Flow
46.64
FCF Yield
-0.8%
EBITDA / EV
3.0%
Sales Yield (1/P·S)
0.1283
Shareholder Yield
Div + net buyback / mktcap
-0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
14.0%
Return on Assets
9.4%
Net Margin
12.6%
Operating Margin
15.8%
Gross Profit / Assets
Novy-Marx GPA
57.8%
Current Ratio
2.67
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.027
External Financing
Net issuance — lower=better
0.006
MomentumPrice trend strength over different horizons
6M Return
6.6%
12M Return
2.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-1.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.04
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
19.4%
Earnings Growth (YoY)
15.5%
Earnings Stability (CV)
Lower = more stable
0.237
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
5
Dividend Yield
0.0%
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
95
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
96
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
96
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity